[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Obsessive-compulsive disorder (OCD) is characterized by obsessions, compulsions, or both, which cause significant personal distress or social dysfunction. OCD is a common psychiatric illness with a prevalence of 1-2%. Because most people have regular contact with primary health care services, the patient with OCD is likely to see their general practitioner even though psychological problems may not be the main reason for consultation. Early recognition of the disorder facilitates early intervention. This reduces distress, disability and burden of illness. Pharmacological treatment with serotonin reuptake inhibitors (SRI) and cognitive-behavioral therapy have both been proven to be effective and are evidence based.
Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck.
A
A
Kordon
A
A
Broocks
F
F
Hohagen
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use; D001521:Behavior Therapy; D002648:Child; D015283:Citalopram / Q000008:administration & dosage / Q000627:therapeutic use; D002997:Clomipramine / Q000008:administration & dosage / Q000627:therapeutic use; D003863:Depression / Q000175:diagnosis; D003937:Diagnosis, Differential; D004485:Eczema / Q000175:diagnosis / Q000209:etiology; D005194:Family Practice; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000627:therapeutic use; D016666:Fluvoxamine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology / Q000628:therapy; D017374:Paroxetine / Q000008:administration & dosage / Q000627:therapeutic use; D011613:Psychotherapy; D012559:Schizophrenia / Q000175:diagnosis; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D020280:Sertraline / Q000008:administration & dosage / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D013997:Time Factors; D014256:Trichotillomania / Q000175:diagnosis / Q000209:etiology
D014151:Anti-Anxiety Agents; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D015283:Citalopram; D002997:Clomipramine; D005473:Fluoxetine; D016666:Fluvoxamine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline